Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

216.56
Delayed Data
As of Apr 29
 -2.29 / -1.05%
Today’s Change
212.67
Today|||52-Week Range
340.34
-30.70%
Year-to-Date

Today’s Trading

Previous close218.85
Today’s open219.01
Day’s range214.06 - 219.40
Volume3,769,791
Average volume (3 months)4,006,112
Market cap$85.6B
Dividend yield--
Data as of 4:01pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+5.21%
Earnings growth (next 5 years)+13.00%
Revenue growth (last year)+15.38%
P/E ratioNM
Price/Sales7.63
Price/Book1.19

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co-0.93-1.22%
CELGCelgene-4.62-4.28%
AZNAstraZeneca-0.31-1.06%
ABBVAbbVie-0.20-0.33%
Data as of 4:04pm ET, 04/29/2016

Financials

Next reporting dateMay 10, 2016
EPS forecast (this quarter)$3.04
Annual revenue (last year)$15.1B
Annual profit (last year)$3.9B
Net profit margin-19.06%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
President-Generic &
Global Operations, EVP
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers

Search for Jobs